PharmaBlock Sciences (Nanjing), Inc.

SZSE:300725 Stock Report

Market Cap: CN¥6.9b

PharmaBlock Sciences (Nanjing) Future Growth

Future criteria checks 4/6

PharmaBlock Sciences (Nanjing) is forecast to grow earnings and revenue by 28.5% and 16.4% per annum respectively. EPS is expected to grow by 28.4% per annum. Return on equity is forecast to be 9.1% in 3 years.

Key information

28.5%

Earnings growth rate

28.4%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth rate16.4%
Future return on equity9.1%
Analyst coverage

Low

Last updated03 Sep 2024

Recent future growth updates

Recent updates

PharmaBlock Sciences (Nanjing) (SZSE:300725) Takes On Some Risk With Its Use Of Debt

Nov 22
PharmaBlock Sciences (Nanjing) (SZSE:300725) Takes On Some Risk With Its Use Of Debt

PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

Sep 30
PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Aug 23
PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

Jul 31
We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

Jun 12
PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Apr 21
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

Mar 07
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

Earnings and Revenue Growth Forecasts

SZSE:300725 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,339358N/A3762
12/31/20252,081289N/A4383
12/31/20241,825231N/A5793
9/30/20241,562175192287N/A
6/30/20241,626182104270N/A
3/31/20241,71918958227N/A
12/31/20231,725197-69247N/A
9/30/20231,701219-169209N/A
6/30/20231,704275-133320N/A
3/31/20231,642301-270302N/A
1/1/20231,595314-311247N/A
9/30/20221,483294-487144N/A
6/30/20221,315258-55688N/A
3/31/20221,251488-497100N/A
12/31/20211,202487-268238N/A
9/30/20211,200484-4380N/A
6/30/20211,184478112342N/A
3/31/20211,137226253376N/A
12/31/20201,022184196272N/A
9/30/2020923177135241N/A
6/30/202083117090222N/A
3/31/20206811471159N/A
12/31/2019662152-46127N/A
9/30/20196031577129N/A
6/30/201955814925116N/A
3/31/201953114787158N/A
12/31/2018478133112160N/A
9/30/20184171095593N/A
6/30/201836289N/A106N/A
3/31/201831975N/A79N/A
12/31/201727367N/A55N/A
9/30/201724462N/A58N/A
6/30/201721944N/A29N/A
3/31/201719637N/A16N/A
12/31/201618836N/A23N/A
9/30/201618330N/A23N/A
6/30/201617731N/A27N/A
3/31/201615625N/A27N/A
12/31/201513620N/A28N/A
12/31/20147722N/A12N/A
12/31/20135918N/A18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300725's forecast earnings growth (28.5% per year) is above the savings rate (2.8%).

Earnings vs Market: 300725's earnings (28.5% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 300725's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300725's revenue (16.4% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300725's revenue (16.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300725's Return on Equity is forecast to be low in 3 years time (9.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y